Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Application of Molecular Evaluation Instrument for Lung Cancer Diagnosis and Treatment

NCT06086587 is registered in ClinicalTrials.gov with Shanghai Pulmonary Hospital, Shanghai, China as lead sponsor.

NCT NCT06086587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06086587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Application of Molecular Evaluation Instrument for Lung Cancer Diagnosis and Treatment
Lead sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Phase
Observational
Overall status
Unknown status
Start date
November 7, 2023
Completion date
October 31, 2025
Enrollment
500 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer